• Product
  • Our Science
    • Pipeline
    • Focus Areas
    • Research and Medical Grants
  • Patients
    • Patient Resources
  • Investors
    • Stock Information
    • News & SEC Filings
    • Financial Results
    • Shareholder Information
    • Analyst Coverage

    EVENTS, PRESENTATIONS & PUBLICATIONS

    • Past Events
    • Upcoming Events
    • Presentations
    • Publications
  • Company
    • Our Strategy
    • Company Leadership
    • Careers
    • Corporate Governance
    • Compliance and Transparency
  • News & Resources
    • News
Contact Us
  • Product

    • Pipeline
    • Focus Areas
    • Research and Medical Grants

    Pipeline

    Development Programs

    Building a broad portfolio of respiratory therapeutics

    Learn More
    Our Science

    • Patient Resources

    Patient Resources

    Educational materials

    Helping to understand and improve respiratory care

    Learn More
    Patients

  • January 5

    Company Presentation

    Developing innovative therapies for the treatment of respiratory diseases

    Download Now

    • Stock Information
    • News & SEC Filings
    • Financial Results
    • Shareholder Information
    • Analyst Coverage

    EVENTS, PRESENTATIONS & PUBLICATIONS

    • Past Events
    • Upcoming Events
    • Presentations
    • Publications
    Investors

  • We aim to improve health and wellbeing for those affected by chronic respiratory diseases.

    David Zaccardelli

    President and CEO

    • Our Strategy
    • Company Leadership
    • Careers
    • Corporate Governance
    • Compliance and Transparency
    Company

  • Latest News

    Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

    Read More

    • News
    News & Resources
  • Contact Us
Follow Us

© Verona Pharma plc 2024. All rights reserved

  • Website Terms & Conditions
  • Email Alerts
  • Legal Information
  • Cookies
  • Privacy Notice
Get Started
  • Product
  • Our Science
  • Patients
  • Investors
  • Company
  • News & Resources
Investors
  • Stock Information
  • News & SEC Filings
  • Events & Presentations
  • Financial Results
  • Shareholder Information
  • Analyst Coverage
Follow Us